Maintains 'Buy' ratings on SBI Life, HDFC Life, Axis Max Life, and ICICI Prudential Life. For SBI Life, Nuvama sets a target price of ₹2,600, implying over 50% upside. For HDFC Life, the target is ₹790, implying over 48% upside. LIC's retail-weighted premium growth outpaced peers, but total APE growth slowed to 3% YoY.

Nuvama Analysis’s track record: 4 graded calls · 95% CI 15–85%

SBIBullishCalled 08 Sep 2026
Verdict:PENDING

This call hasn't reached its evaluation window yet — the HIT/MISS verdict will appear here once it's graded against real price data. Save it above to find it again from your profile.

Tracking SBI since this call

1-year tracking window
Read the original articleSee Nuvama Analysis’s full track record